Balimek

binimetinib · Pierre Fabre Médicament

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Balimek, covering 2018-03-27 to 2018-03-27. Get the full timeline:

Most recent: EMA Application withdrawn: Balimek (binimetinib) — Pierre Fabre Médicament